[HTML][HTML] Drug-related pneumonitis in cancer treatment during the COVID-19 era

S Cherri, S Noventa, M Fanelli, G Calandra, T Prochilo… - Cancers, 2021 - mdpi.com
Simple Summary Interstitial lung disease is a group of diseases characterized by chronic
lung inflammation that can be related to oncological treatments, such as traditional …

Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era.

S Cherri, S Noventa, M Fanelli, G Calandra… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: Interstitial lung disease is a group of diseases characterized by
chronic lung inflammation that can be related to oncological treatments, such as traditional …

[HTML][HTML] Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era

S Cherri, S Noventa, M Fanelli, G Calandra, T Prochilo… - Cancers, 2021 - ncbi.nlm.nih.gov
Interstitial lung disease is recognized as a group of diseases with a different
etiopathogenesis characterized by chronic lung inflammation with the accumulation of …

Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era.

S Cherri, S Noventa, M Fanelli, G Calandra, T Prochilo… - Cancers, 2021 - europepmc.org
Interstitial lung disease is recognized as a group of diseases with a different
etiopathogenesis characterized by chronic lung inflammation with the accumulation of …

Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era

S Cherri, S Noventa, M Fanelli, G Calandra… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Interstitial lung disease is recognized as a group of diseases with a different
etiopathogenesis characterized by chronic lung inflammation with the accumulation of …

Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era.

S Cherri, S Noventa, M Fanelli, G Calandra, T Prochilo… - Cancers, 2021 - europepmc.org
Interstitial lung disease is recognized as a group of diseases with a different
etiopathogenesis characterized by chronic lung inflammation with the accumulation of …